STAAR Surgical: The ICL Installed Base Keeps Growing But Revenue Per Lens Doesn't

Staar Surgical Company (STAA) reports second-quarter fiscal 2026 earnings on August 5, 2026, with analysts expecting the company to deliver $0.06 per share on consensus revenue of $89.8 million. The central question is whether STAA can sustain the dramatic operational turnaround demonstrated in Q1—when it posted a massive earnings surprise and returned to profitability—or if the momentum will fade amid geopolitical headwinds, pricing pressure, and management's cautious outlook that prompted them to decline formal revenue guidance.

Part 1: Earnings Preview

Staar Surgical Company designs, develops, manufactures, and sells implantable lenses for the eye and companion delivery systems, with its flagship EVO Implantable Collamer Lens (ICL) used to correct myopia and treat cataracts. The company generates significant revenue from international markets, particularly China, and recently brought its Swiss manufacturing facility online to supply 100% of EVO/EVO+ products to China while avoiding tariffs.

For the second quarter ending June 2026, the consensus estimate stands at $0.06 per share on revenue of $89.8 million. The most recently reported quarter (Q1 2026) delivered actual EPS of $0.29, crushing estimates and marking a dramatic reversal from the year-ago period when STAA reported -$0.23 per share. The year-over-year comparison shows analysts expecting a swing from a loss to profitability, representing +126.09% growth.

Three key themes define this earnings story:

China Normalization and Inventory Dynamics: After distributor inventory destocking pressured results throughout 2025, Q1 2026 saw China revenue surge to $47.4 million as inventories normalized to contractual 6-month targets. Investors will watch whether this normalization continues or if demand softens, particularly given management's cautious Q3 outlook citing macro and geopolitical uncertainty.

Margin Expansion and Path to Profitability: Q1 delivered a stunning turnaround with adjusted EBITDA of $24.4 million (versus -$26.3 million prior year) and gross margin reaching 73.6% (versus 65.8%). Management reiterated a 75% gross margin target for year-end 2026 and a $225 million spending target. The question is whether pricing pressure—ASPs declined high single digits in Q1—will erode these gains or if operational leverage can offset headwinds.

Geographic Mix and Geopolitical Risk: While China rebounded sharply, management flagged headwinds in the Middle East and India, and U.S. revenue of just over $6 million (+22% YoY) remains a small portion of the mix. The company's heavy China exposure (over 50% of Q1 revenue) creates both opportunity and concentration risk, especially as management declined to comment on the ~$311-312 million full-year consensus due to limited visibility.

Analysts remain cautiously optimistic but divided. The consensus has shifted toward Hold territory with 10 of 13 analysts at Hold, 2 at Strong Buy, and 1 at Strong Sell. The average price target of $29.20 implies meaningful upside from current levels, but the recent addition of a Strong Sell rating and deteriorating sentiment trend suggest growing concern about sustainability. Analysts are watching whether STAA can maintain momentum without formal guidance and whether the Q1 beat was a turning point or a temporary spike driven by inventory normalization rather than underlying demand strength.

Part 2: Historical Earnings Performance

STAA has delivered a highly volatile earnings track record over the past four quarters, with massive surprises in both directions. The company beat estimates in three of the last four quarters but missed badly in Q4 2025, creating an unpredictable pattern.

The most recent quarter (Q1 2026) produced a stunning +1,066.67% surprise, reporting $0.29 versus an estimate of -$0.03. This followed Q3 2025's extraordinary +500.00% beat ($0.30 versus $0.05 expected). However, sandwiched between these blowout results was Q4 2025's -533.33% miss (-$0.13 versus $0.03 expected), demonstrating the company's operational volatility during its turnaround phase.

The pattern suggests STAA is in transition—moving from consistent losses in early 2025 toward profitability, but with significant quarter-to-quarter variability. The two massive beats coincided with China market normalization and operational improvements, while the Q4 miss reflected lingering inventory issues and cost pressures. Given management's refusal to provide formal guidance and cautious commentary about Q3, investors should expect continued volatility even as the underlying trajectory improves.

Note: These figures reflect diluted GAAP earnings per share, reported before non-recurring items, and may differ from the non-GAAP figures used by some sources.

Part 2.1: Price Behavior Around Earnings

STAA typically reports earnings after market close, meaning Day 0 reflects anticipatory trading before results are released, while Day +1 captures the market's first full reaction to the actual numbers.

Historical price action shows significant volatility around earnings, with an average absolute Day 0 move of 2.48% expanding to 6.75% by Day +1. The Day +1 range averages 10.09%, indicating substantial intraday swings as investors digest results.

The most recent earnings (May 2026) produced a +4.33% Day 0 move and +8.88% Day +1 gain following the massive earnings beat, with a Day +1 range of 15.17% reflecting high conviction in the turnaround story. In contrast, the February 2025 report triggered a -24.68% Day +1 collapse when the company missed estimates badly, demonstrating how quickly sentiment can reverse.

The pattern shows STAA tends to make its largest moves on Day +1 rather than Day 0, suggesting the market waits for actual results and management commentary before committing. Beats have driven strong rallies (August 2024: +11.03% Day +1), while misses trigger sharp selloffs, making position sizing and risk management critical heading into the print.

Part 2.2: Options Market Expected Move

The options market is pricing a 5.64% expected move for the August 21 expiration, which sits below the 6.75% average Day +1 move but well within the historical range. This suggests options traders are anticipating meaningful volatility but not the extreme swings seen in recent quarters, possibly reflecting reduced conviction given management's cautious outlook and lack of formal guidance.

Part 3: What Analysts Are Saying

Analyst sentiment on STAA has deteriorated recently, with the consensus average recommendation at 3.15 (between Hold and Buy, but closer to Hold). The rating breakdown shows 2 Strong Buys, 10 Holds, and 1 Strong Sell among 13 analysts covering the stock—a defensive posture that reflects uncertainty about the sustainability of Q1's turnaround.

The shift is notable: one month ago the average recommendation stood at 3.33 with no Strong Sell ratings, indicating growing caution among the analyst community. The addition of a Strong Sell rating and the heavy concentration in Hold ratings (77% of coverage) suggests analysts are adopting a wait-and-see approach rather than chasing the Q1 momentum.

The consensus price target of $29.20 implies 21.1% upside from the current price of $24.12, with estimates ranging from a low of $20.00 (-17.1% downside) to a high of $40.00 (+65.8% upside). This wide range reflects deep disagreement about STAA's valuation—bulls see the Q1 results as proof of a sustainable turnaround with significant operating leverage ahead, while bears worry about China concentration risk, pricing pressure, and management's refusal to provide guidance as signs that visibility remains poor and the path forward uncertain.

Part 4: Technical Picture

The Barchart Technical Opinion has shifted dramatically bearish, currently showing a Sell signal at 8%—unchanged from last week but a sharp reversal from the Buy signal at 48% just one month ago. This deterioration reflects the stock's recent weakness and breakdown below key moving averages.

Timeframe Analysis:

• Short-term (50% Sell): Moderate sell signal indicates near-term momentum has turned negative heading into earnings
• Medium-term (50% Buy): Conflicting buy signal suggests the intermediate trend remains constructive despite recent weakness
• Long-term (Hold): Neutral reading reflects uncertainty about whether the longer-term trend will resume or fail

Trend Characteristics: The signal strength is rated as Minimum and the direction is Weakening, indicating a fragile technical environment with deteriorating momentum that could amplify volatility around the earnings release.

The stock is trading at $24.12, positioned below the 5-day ($24.18), 20-day ($25.50), 50-day ($27.78), and 100-day ($26.00) moving averages, but slightly below the 200-day average at $24.31. This configuration shows STAA has broken down from its recent highs near $28 and is now testing long-term support.

The only bullish technical element is the stock's position above the 10-day moving average at $23.88, suggesting very short-term stabilization. However, the cluster of resistance overhead—particularly the 20-day at $25.50 and 50-day at $27.78—creates a challenging setup. The stock would need a significant earnings beat and strong guidance to reclaim these levels. Conversely, a miss or continued lack of guidance could push STAA below the 200-day average, potentially triggering further technical selling. The overall setup is cautionary, with weakening momentum and multiple resistance levels suggesting the path of least resistance is lower unless earnings provide a strong positive catalyst.